Gastric cancer

There are 599 papers on gastric cancer in aging research: 31 trials and 343 observational studies in people, 10 in animals, 11 in cells, 142 reviews.

Disease

599 papers study it159 more mention it205 findings

50 new papers in 30 daysSee all 758 papers on gastric cancer

“In the SIT dataset, after 29.4 years of follow-up, H. pylori treatment was associated with a 34% reduction in GC incidence (HR = 0.66, 95% CI 0.46–0.95).”
Genetically determined heterogeneous treatment effects of Helicobacter pylori eradication for targeted gastric cancer preventionInnovation (Cambridge (Mass.))2026doi:10.1016/j.xinn.2026.101402
  • Human trial31
  • Humans343
  • Animals10
  • Cells11
  • In silico60

Interventions

13

Vitamin B12

no changein humans1OR 1.04

1 study
  1. Vitamin B12 showed no clear effect on gastric cancer in humans (OR 1.04, 95% CI 0.99–1.10 per quartile of intake).

    “Overall, dietary vitamin B12 intake was not associated with gastric cancer risk”

    Reviewper quartile of dietary intake

    Dietary intake of vitamin B12 (cobalamin) and gastric cancer risk: a pooled analysis within the StoP Project

    European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)

More on Vitamin B12

Metformin

no changein humans1

1 study
  1. Metformin showed no clear effect on gastric cancer in humans (type 2 diabetes; short-term use).

    “short-term use (< 3 years) did not show a significant benefit.”

    Reviewtype 2 diabetes; short-term use< 3 years

    Metformin use and the risk of gastric cancer: a systematic review and meta-analysis

    Research SquarePreprint

More on Metformin

Seafood

no changein humans1

1 study
  1. Seafood was not clearly linked with gastric cancer in humans.

    “no association was found for unprocessed red meat, poultry, or seafood.”

    Humans

    Processed meat, unprocessed red meat, poultry, seafood, and egg intake and stomach cancer risk: a pooled analysis of 20 cohorts

    International journal of epidemiology

More on Seafood

Poultry

no changein humans1

1 study
  1. Poultry was not clearly linked with gastric cancer in humans.

    “no association was found for unprocessed red meat, poultry, or seafood.”

    Humans

    Processed meat, unprocessed red meat, poultry, seafood, and egg intake and stomach cancer risk: a pooled analysis of 20 cohorts

    International journal of epidemiology

More on Poultry

Unprocessed red meat

no changein humans1

1 study
  1. Unprocessed red meat was not clearly linked with gastric cancer in humans.

    “no association was found for unprocessed red meat, poultry, or seafood.”

    Humans

    Processed meat, unprocessed red meat, poultry, seafood, and egg intake and stomach cancer risk: a pooled analysis of 20 cohorts

    International journal of epidemiology

More on Unprocessed red meat

Riboflavin

no changein humans1OR 0.97

1 study
  1. Riboflavin was not clearly linked with gastric cancer in humans (per one-quartile increase in intake) (OR=0.97 (95% CI = 0.93-1.02)).

    “B2, OR=0.97 (95% CI = 0.93-1.02)”

    Humansper one-quartile increase in intake

    Dietary intake of vitamins B1, B2, B3, and B6, and the risk of gastric cancer: pooled analyses within the Stomach cancer Pooling (Stop) project

    European journal of nutrition

More on Riboflavin

Helicobacter pylori eradication

downin humans1

1 study
  1. Helicobacter pylori eradication prevents gastric cancer in humans (even in the presence of dysplasia or early GC).

    “H. pylori eradication can prevent future GC incidence, even in the presence of dysplasia or early GC”

    Revieweven in the presence of dysplasia or early GC

    Helicobacter pylori eradication and gastric cancer prevention: current evidence and future perspectives

    Expert review of gastroenterology & hepatology

More on Helicobacter pylori eradication

Gastric cancer screening

no changein humans1

1 study
  1. Gastric cancer screening was not clearly linked with gastric cancer in humans (P for trend = 0.079).

    “Screening compliance was not significantly associated with ETI or gastric cancer incidence.”

    Humans8.2 yearsn = 2,394,562

    Impact of screening compliance on gastric cancer risk and eligibility for endoscopic treatment: a nationwide population-based cohort study

    European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)

More on Gastric cancer screening

Pro-inflammatory diet

no changein humans1

1 study
  1. Pro-inflammatory diet showed no clear effect on gastric cancer in humans (cohort studies).

    “No significant associations were found for gastric or pancreatic cancers in cohort studies.”

    Reviewcohort studies

    Dietary inflammatory index and risk of major digestive tract cancers: a GRADE-assessed systematic review and dose-response meta-analysis

    BMC cancer

More on Pro-inflammatory diet

Nortriptyline

downin humans1

1 study
  1. Nortriptyline decreases gastric cancer in gastric cancer models.

    “Nor administration attenuates lysosomal exocytosis-mediated senescence-associated secretory phenotype (SASP) and reduces aggressive phenotypes in gastric cancer models”

    Animalsin gastric cancer models

    Nortriptyline Inhibits Lysosomal Exocytosis-Mediated SASP During Gastric Cancer Progression via Targeting HOXA1-PITX2 Phase Separation

    Advanced science (Weinheim, Baden-Wurttemberg, Germany)

More on Nortriptyline

All 13

Effects

4

Deaths

upin humans1

1 study
  1. Gastric cancer is linked with higher deaths in humans (1990 to 2021 global absolute burden).

    “Compared to 1990, the number of GC cases and deaths increased in 2021”

    Humans1990 to 2021 global absolute burdenstomach1990 to 2021

    Gastric cancer burden from 1990 to 2021, Joinpoint analysis, projections to 2036, and health inequality assessment: Findings from the Global Burden of Disease study 2021

    Medicine

Age-standardized mortality rate

downin humans1

1 study
  1. Gastric cancer is linked with lower age-standardized mortality rate in humans (1990 to 2021 global trend).

    “meanwhile, the age-standardized incidence rate, age-standardized mortality rate, and age-standardized disability-adjusted life years rate declined, respectively.”

    Humans1990 to 2021 global trendstomach1990 to 2021

    Gastric cancer burden from 1990 to 2021, Joinpoint analysis, projections to 2036, and health inequality assessment: Findings from the Global Burden of Disease study 2021

    Medicine

GSTM2

downin human cells1

1 study
  1. Gastric cancer decreases GSTM2 in human cells (GC cell lines).

    “showing high expression of CCNB1, NUF2, and THBS2 and low expression of GSTM2 in GC cell lines”

    CellsGC cell lines

    Causal relationship between metabolic syndrome and gastric cancer: insights from comprehensive analysis and biomarker identification

    Translational cancer research

More on GSTM2

CCNB1

upin human cells1

1 study
  1. Gastric cancer increases CCNB1 in human cells (GC cell lines).

    “showing high expression of CCNB1, NUF2, and THBS2 and low expression of GSTM2 in GC cell lines”

    CellsGC cell lines

    Causal relationship between metabolic syndrome and gastric cancer: insights from comprehensive analysis and biomarker identification

    Translational cancer research

More on CCNB1

Upstream

8

Jiangsu Province cancer registry data (2010-2021)

downin humans1

1 study
  1. Jiangsu Province cancer registry data (2010-2021) is linked with lower gastric cancer in humans.

    “age-standardized incidence and mortality declined for esophageal, gastric, and liver cancer”

    Humans2010-2021

    Trends and future burden of major digestive system cancers in Jiangsu Province, China, 2010-2030

    Frontiers in oncology

New GC instances

upin humans1

1 study
  1. New GC instances are linked with higher gastric cancer in humans (nearly twofold increase).

    “From 1990 to 2021, Iran saw nearly a twofold increase in new GC instances”

    Humansstomach1990 to 2021

    Gastric Cancer Incidence in Iran: Trends and Projections to 2030 based on Global Burden of Disease 2021 Estimates

    Journal of gastrointestinal cancer

Age-standardized incidence rate

downin humans1

1 study
  1. Age-standardized incidence rate is linked with lower gastric cancer in humans (from 23.12 to 14.37 per 100,000).

    “however, the age-standardized incidence rate (ASIR) significantly fell from 23.12 to 14.37 per 100,000 individuals.”

    Humansstomach1990 to 2021

    Gastric Cancer Incidence in Iran: Trends and Projections to 2030 based on Global Burden of Disease 2021 Estimates

    Journal of gastrointestinal cancer

MMP12

downin human cells1

1 study
  1. MMP12 protects against gastric cancer in GC cells.

    “cellular experiments demonstrated that the MMP12 gene serves as a protective factor in GC cells.”

    Cellsin GC cells

    Prognostic prediction and immune infiltration analysis based on lysosome and senescence state identifies MMP12 as a novel therapy target in gastric cancer

    International immunopharmacology

More on MMP12

Parkinson's disease

no changein humans1OR 0.94

1 study
  1. Parkinson's disease was not clearly linked with gastric cancer in humans (Genetically predicted Parkinson's disease) (OR 0.94, 95% CI 0.89–0.99; P=0.22; reported interval conflicts with the null conclusion and P-value).

    “As for GC, no causal effect was found (OR =0.94, 95% CI: 0.89-0.99; P=0.22).”

    HumansGenetically predicted Parkinson's disease

    Parkinson's disease and the risk of gastrointestinal cancers: a two-sample Mendelian randomization study

    Journal of gastrointestinal oncology

More on Parkinson's disease

Anti-intrinsic factor antibodies

no changein humans1

1 study
  1. Anti-intrinsic factor antibodies were not clearly linked with gastric cancer in humans.

    “In both cohorts, anti-intrinsic factor antibody seroprevalence was less than 2% among cases as well as controls and not statistically associated with GC risk.”

    Humansstomach

    Association of Antiparietal Cell and Anti-Intrinsic Factor Antibodies With Risk of Gastric Cancer

    JAMA oncology

More on Anti-intrinsic factor antibodies

Antiparietal cell antibodies

no changein humans1OR 0.99

1 study
  1. Antiparietal cell antibodies were not clearly linked with gastric cancer in H pylori-seronegative men (OR 0.99, 95% CI 0.32-3.04).

    “In the ATBC Study, APCA seropositivity was not associated with GC among either H pylori-seronegative men (OR, 0.99; 95% CI, 0.32-3.04)”

    Humansin H pylori-seronegative menstomachmales

    Association of Antiparietal Cell and Anti-Intrinsic Factor Antibodies With Risk of Gastric Cancer

    JAMA oncology

More on Antiparietal cell antibodies

Triglyceride

no changein humans1

1 study
  1. Triglyceride was not clearly linked with gastric cancer in humans.

    “Triglyceride was not independently related with gastric cancer risk among both pre- and postmenopausal women.”

    Humansmean 8.26 yearsfemales

    Nationwide cohort study: cholesterol level is inversely related with the risk of gastric cancer among postmenopausal women

    Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association

More on Triglyceride

Associations

154

Helicobacter pylori eradication

downin humans5HR 0.44–0.66

5 studies
  1. Helicobacter pylori eradication lowers the risk of gastric cancer (HR 0.66, 95% CI 0.46–0.95).

    “In the SIT dataset, after 29.4 years of follow-up, H. pylori treatment was associated with a 34% reduction in GC incidence (HR = 0.66, 95% CI 0.46–0.95).”

    Human trial29.4 yearsn = 1,811

    Genetic score may help target stomach cancer prevention

    Innovation (Cambridge (Mass.))

  2. Helicobacter pylori eradication lowers the risk of gastric cancer in humans (MITS; high-treatment-benefit individuals identified using PTBS) (HR 0.44, 95% CI 0.35–0.54; NNT 56).

    “With the PTBS, targeting the high-treatment-benefit individuals conferred stronger protection against GC”

    Human trialMITS; high-treatment-benefit individuals identified using PTBSn = 1,740

    Genetic score may help target stomach cancer prevention

    Innovation (Cambridge (Mass.))

  3. Helicobacter pylori eradication is linked with a lower risk of gastric cancer in humans (SIR 0.56 (95% CI, 0.52-0.61) in 70-74 age group).

    “GC incidence and mortality rates were significantly lower in H pylori-treated individuals than in the general population across all age-groups”

    Humans

    Preventive Effect of Helicobacter pylori Treatment on Gastric Cancer Incidence and Mortality: A Korean Population Study

    Gastroenterology

  4. Helicobacter pylori eradication lowers the risk of gastric cancer in humans.

    “Helicobacter pylori eradication reduces subsequent gastric cancer risk”

    Review

    Multimodal Risk Stratification and Surveillance for Gastric Cancer in Chronic Atrophic Gastritis and Gastric Intestinal Metaplasia: Integrating Histology, Endoscopy, Biomarkers, and Artificial Intelligence

    Clinical and experimental gastroenterology

  5. Helicobacter pylori eradication lowers the risk of gastric cancer in humans (combined with risk-stratified screening).

    “Population-wide Helicobacter pylori eradication combined with risk-stratified screening represents an effective strategy to reduce gastric cancer burden.”

    Reviewcombined with risk-stratified screening

    Infection-driven cancers in Asia: implications from epidemiological transitions

    The Lancet regional health. Western Pacific

  6. Helicobacter pylori eradication lowers the risk of gastric cancer in humans (high-risk areas).

    “Large-scale randomized controlled intervention trials in high-risk areas have provided robust evidence to support H. pylori eradication as an effective primary prevention strategy.”

    Reviewhigh-risk areas

    Gastric cancer in China: Epidemiology, risk factors, and screening

    Chinese journal of cancer research = Chung-kuo yen cheng yen chiu

More on Helicobacter pylori eradication

Metformin

downin humans3HR 0.448–0.72

3 studies
  1. Metformin is linked with a lower risk of gastric cancer in humans (Genetically instrumented metformin treatment) (OR <0.1; P <.05).

    “inverse-variance weighting estimates demonstrated a protective effect of metformin against esophageal, gastric, and colorectal cancers (all odds ratios <0.1, all P <.05).”

    HumansGenetically instrumented metformin treatment

    Metformin treatment and reduction of gastrointestinal cancer risk: A 2-sample Mendelian randomization study

    Medicine

  2. Metformin is linked with a lower risk of gastric cancer in patients with type 2 diabetes (HR 0.448, 95% CI 0.359-0.558).

    “The overall hazard ratio (95% confidence intervals) of 0.448 (0.359-0.558) suggested a significantly lower risk among ever users.”

    Humansin patients with type 2 diabetes

    Metformin reduces gastric cancer risk in patients with type 2 diabetes mellitus

    Aging

  3. Metformin is associated with gastric cancer in humans (type 2 diabetes) (HR 0.72, 95% CI 0.39–0.87).

    “metformin use was associated with a significant reduction in the risk of gastric cancer (HR = 0.72; 95% CI: 0.39–0.87; P = 0.0008).”

    Reviewtype 2 diabetes

    Metformin use and the risk of gastric cancer: a systematic review and meta-analysis

    Research SquarePreprint

More on Metformin

Helicobacter pylori

upin humans3HR 2.03

3 studies
  1. Helicobacter pylori is linked with a higher risk of gastric cancer in humans (HR 2.03, 95% CI: 1.25-3.26).

    “H. pylori-associated atrophic gastritis (HPAG) was significantly associated with increased risks of gastric cancer (HR 2.03; 95% CI: 1.25-3.26; p = 0.012)”

    Humansn = 1,252

    Helicobacter pylori-Associated Atrophic Gastritis and Risk of Gastric and Breast Cancer: A Prospective Cohort Study in Thailand

    Asian Pacific journal of cancer prevention : APJCP

  2. Helicobacter pylori raises the risk of gastric cancer in humans.

    “The literature review highlighted Helicobacter pylori infection as the predominant risk factor”

    Reviewstomach

    Gastric cancer burden, risk factors, and early detection strategies in Latin America and Colombia

    Research SquarePreprint

  3. Helicobacter pylori raises the risk of gastric cancer in humans (H. pylori infection).

    “Furthermore, H. pylori induces cellular senescence and promotes atrophy progression and finally increases the gastric cancer risk.”

    ReviewH. pylori infection

    Association of Helicobacter pylori related chronic atrophic gastritis and gastric cancer risk: a literature review

    Frontiers in medicine

More on Helicobacter pylori

Smoking

upin humans3

3 studies
  1. Smoking is linked with a higher risk of gastric cancer in humans.

    “Smoking remained the leading attributable risk factor, particularly in China.”

    Humans

    Temporal trends, risk factors, and future projections of gastric cancer burden in China, India, and the United States: a GBD 2023 analysis

    Discover oncology

  2. Smoking is associated with gastric cancer in humans.

    “Smoking, high sodium intake, and high alcohol use together accounted for a substantial but shrinking age-standardized share of GC deaths and DALYs.”

    Humans

    Gastric Cancer in China, 1990 to 2023: Trends, Modifiable Risks, and Prevention Priorities

    Journal of clinical gastroenterology

  3. Smoking is linked with a higher risk of gastric cancer in humans (young adults) (p < 0.001).

    “Multiple risk factorswere significantly associated with PGLs and EOGC, including H. pylori infection (p = 0.022), increasing age (p < 0.001), a family history of gastric cancer (p < 0.001), poor dietary habits (p < 0.001), obesity (p < 0.001), and smoking (p < 0.001).”

    Humansyoung adults

    A Longitudinal Study of Premalignant Gastric Lesions and Early Onset Gastric Cancer Among Young Adults in Central Saudi Arabia

    Current oncology (Toronto, Ont.)

More on Smoking

OLGIM

upin humans2RR 12.38

2 studies
  1. OLGIM is associated with gastric cancer in humans (OLGIM stages III-IV compared with stages 0-II) (RR 12.38).

    “stages III-IV were associated with substantially higher risks of gastric cancer than stages 0-II, with risk ratios of 32.31 and 12.38, respectively.”

    ReviewOLGIM stages III-IV compared with stages 0-II

    Multimodal Risk Stratification and Surveillance for Gastric Cancer in Chronic Atrophic Gastritis and Gastric Intestinal Metaplasia: Integrating Histology, Endoscopy, Biomarkers, and Artificial Intelligence

    Clinical and experimental gastroenterology

  2. OLGIM is associated with gastric cancer in humans (Observational studies; OLGIM stage II) (OR 3.63; 95% CI 2.90–4.55).

    “and OLGIM II (OR 3.63; 95% CI 2.90-4.55; I2 = 0%).”

    ReviewObservational studies; OLGIM stage II

    Intermediate OLGA/OLGIM Stages as Early Risk Markers for Gastric Cancer: A Systematic Review and Meta-Analysis

    Helicobacter

More on OLGIM

OLGA

upin humans2RR 32.31

2 studies
  1. OLGA is associated with gastric cancer in humans (OLGA stages III-IV compared with stages 0-II) (RR 32.31).

    “stages III-IV were associated with substantially higher risks of gastric cancer than stages 0-II, with risk ratios of 32.31 and 12.38, respectively.”

    ReviewOLGA stages III-IV compared with stages 0-II

    Multimodal Risk Stratification and Surveillance for Gastric Cancer in Chronic Atrophic Gastritis and Gastric Intestinal Metaplasia: Integrating Histology, Endoscopy, Biomarkers, and Artificial Intelligence

    Clinical and experimental gastroenterology

  2. OLGA is associated with gastric cancer in humans (Observational studies; OLGA stage II) (OR 2.77; 95% CI 1.83–4.20).

    “Intermediate stages were also associated with GC in observational studies: OLGA II (OR 2.77; 95% CI 1.83-4.20; I2 = 71%)”

    ReviewObservational studies; OLGA stage II

    Intermediate OLGA/OLGIM Stages as Early Risk Markers for Gastric Cancer: A Systematic Review and Meta-Analysis

    Helicobacter

More on OLGA

Helicobacter pylori infection

upin humans2

2 studies
  1. Helicobacter pylori infection raises the risk of gastric cancer in humans.

    “Helicobacter pylori is a major causal factor, but mucosal damage, hereditary susceptibility, and other exposures affect risk.”

    Review

    Gastric Cancer: Global Epidemiology, Risk Factors, Helicobacter pylori Eradication, and Risk-Based Screening

    Journal of clinical medicine

  2. Helicobacter pylori infection raises the risk of gastric cancer in humans (Helicobacter pylori infection).

    “Helicobacter pylori (H. pylori) infection is chronic and etiologically linked to gastric cancer (GC) derived from gastric epithelium.”

    ReviewHelicobacter pylori infection

    Detection and Treatment of Helicobacter pylori: Problems and Advances

    Gastroenterology research and practice

More on Helicobacter pylori infection

Alcohol-related liver disease

upin humans2HR 1.4

2 studies
  1. Alcohol-related liver disease is linked with a higher risk of gastric cancer in humans (IRR 2.41).

    “ALD was associated with an elevated risk of esophageal cancer (IRR, 5.98) and stomach cancer (IRR, 2.41)”

    Humansn = 43,994

    Differential Cancer Risks and Noninvasive Predictors in MASLD, MetALD, and ALD: A Longitudinal Analysis

    Gut and liver

  2. Alcohol-related liver disease is linked with a higher risk of gastric cancer in humans (cohort of 362,285 individuals) (HR 1.40 (95% CI: 1.16-1.68)).

    “and 1.40 (1.16-1.68) for ALD.”

    Humanscohort of 362,285 individualsn = 362,285

    Subtype-specific associations of steatotic liver disease with gastric and esophageal cancers: a nationwide cohort study

    Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association

More on Alcohol-related liver disease

Microbiome composition

upin humans2

2 studies
  1. Microbiome composition predicts gastric cancer in humans (training set) (AUC 0.96, 0.87, and 0.96).

    “AUC values in the training set reached 0.96, 0.87, and 0.96 for oral, gastric fluid and gastric mucosa classifiers respectively”

    Humanstraining set

    The microbiome of host saliva, gastric fluid, and gastric mucosa as accurate diagnostic tools for gastric cancer detection

    Journal of translational medicine

  2. Microbiome composition raises the risk of gastric cancer in gastric carcinogenesis.

    “gastric microbiome including Helicobacter pylori and diverse non-H. pylori bacteria, fungi, and viruses actively contribute to gastric carcinogenesis”

    Reviewin gastric carcinogenesis

    Unveiling the Gastric Microbiome: Novel Insights into Early Detection and Pathogenesis of Gastric Cancer

    Probiotics and antimicrobial proteins

More on Microbiome composition

Helicobacter pylori

upin humans2

2 studies
  1. Helicobacter pylori raises the risk of gastric cancer in Korean diaspora populations.

    “gastric cancer risk in Korean migrants reflects the interaction of pre-migration exposures, host susceptibility, and post-migration environmental change.”

    Reviewin Korean diaspora populations

    Beyond Helicobacter pylori: A Multifactorial Framework for Persistent Gastric Cancer Risk in Korean-Born and First-Generation Migrants

    Preprints.orgPreprint

  2. Helicobacter pylori raises the risk of gastric cancer in humans (infection) (PARP 23.66%).

    “For PARP were 34.22% (pickled food), 34.24% (edible hot food) and 23.66%(H. pylori infection).”

    Reviewinfection

    Identification and epidemiological evaluation of gastric cancer risk factors: based on a field synopsis and meta-analysis in Chinese population

    Aging

More on Helicobacter pylori

All 154

Trial sponsors

Funding

25 grants since 2016

National Cancer Institute$23MJapan Society for the Promotion of Science¥29.1MNational Institute of Diabetes and Digestive and Kidney Diseases$838K

Latest

Dec 2025: 18Jan 2026: 43Feb 2026: 43Mar 2026: 47Apr 2026: 5May 2026: 9Jun 2026: 9Jul 2026: 16Aug 2026: 31Sep 2026: 41Oct 2026: 46Nov 2026: 18326 papers in 12 months

See all 758 papers on gastric cancer